Samuel Heath
Rheumatology · Willow Grove, PANPI 1043937089
Payments from drug & device makers
Across 282 payments — averaging $22.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$1K
- Amgen$1K
- AbbVie$818
- UCB, Inc.$529
- Johnson & Johnson$493
- Pfizer$341
- plus $2K from 22 others
What the payments were for
- Consulting fees$73612%
- Food & beverage$5,62088%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 37 | $1,218 |
| Amgen | 70 | $1,145 |
| AbbVie | 49 | $818 |
| UCB, Inc. | 19 | $529 |
| Johnson & Johnson | 17 | $493 |
| Pfizer | 15 | $341 |
| AstraZeneca(2 entities) | 14 | $327 |
| Organon | 12 | $280 |
| Lilly USA, LLC | 8 | $173 |
| Boehringer Ingelheim | 4 | $134 |
| Zimmer Biomet | 2 | $133 |
| Genentech USA, Inc. | 6 | $132 |
| Radius Health, Inc. | 5 | $126 |
| Kyowa Kirin, Inc. | 2 | $59 |
| Fresenius Kabi USA, LLC | 3 | $58 |
| Sandoz | 3 | $53 |
| GSK | 2 | $49 |
| Aurinia Pharma U.S., Inc. | 2 | $47 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $43 |
| Biocon Biologics Inc | 2 | $40 |
| Mallinckrodt Hospital Products Inc. | 1 | $35 |
| Scilex Pharmaceuticals Inc. | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $17 |
| Sobi, Inc | 1 | $17 |
| US Oncology Corporate, Inc. | 1 | $16 |
| Qiagen, LLC | 1 | $16 |
| Tonix Medicines, Inc. | 1 | $16 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$115
- SIMPONI ARIA$115
How this compares
$6,356 in reported general payments places this provider in the 55th percentile of 351 rheumatology providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RinvoqUpadacitinib | 31 | $197,806 |
| Humira(Cf) PenAdalimumab | 19 | $155,108 |
| Enbrel SureclickEtanercept | 13 | $91,327 |
| OtezlaApremilast | 11 | $53,137 |
| Hydroxychloroquine Sulfate | 325 | $11,491 |
| XareltoRivaroxaban | 11 | $6,024 |
| MethotrexateMethotrexate Sodium | 202 | $4,838 |
| Duloxetine Hcl | 117 | $2,481 |
| Febuxostat | 12 | $1,993 |
| Celecoxib | 89 | $1,885 |
| Prednisone | 268 | $1,785 |
| Gabapentin | 148 | $1,638 |
| Leflunomide | 39 | $1,615 |
| Colchicine | 24 | $1,501 |
| Leucovorin Calcium | 25 | $1,258 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $818 | $197,80631 claims |
| AmgenOtezla | $1,145 | $53,13711 claims |
| Johnson & JohnsonXarelto | $493 | $6,02411 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $23 | $1,50124 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 351 rheumatology providers in Pennsylvania.
Other rheumatology in Willow Grove
- Charles PritchardWillow Grove$67K
- Alan KivitzDuncansville$27.1M
- Peter MerkelRadnor$6.3M
- Rohit AggarwalPittsburgh$6.2M
- Alexis Ogdie-BeattyPhiladelphia$5.7M
- Jonathan MinerPhiladelphia$3.8M
- Siamak Moghadam-KiaPittsburgh$1.9M
- Frederick MurphyDuncansville$1.2M
- Gregory EmkeyWyomissing$1.2M
- Alan EpsteinPhiladelphia$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.